All In MedTech

Device Trial Radar · NCT04889989

Microwave Ablation in Chinese Patients With Lung Tumors

A Single-Arm, Prospective, Multicenter Study to Evaluate the Effectiveness and Safety of the NeuWave Certus Microwave Ablation System in Chinese Patients With Primary or Secondary Tumors in the Lung

Last checked: Nov 19, 2026Latest source record: Feb 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registry

Status

Terminated

Enrollment

13

Actual

Start

Dec 27, 2021

Primary completion

Oct 22, 2022

Study completion Sep 14, 2023

Sponsor

Lead sponsor
Ethicon, Inc.Public (JNJ)
Sponsor type
Industry
First posted
May 18, 2021

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Adult patients with non-small cell lung cancer (NSCLC) or oligometastatic lung tumors will all receive microwave ablation (MWA) performed percutaneously by doctors who are experienced in lung tumor ablation. 120 patients will participate across 8 clinical study sites all in China.

Conditions

  • Cancer of the Lung

Interventions

  • Microwave AblationDevice

    Percutaneous microwave ablation using the NeuWave Microwave Ablation System for non-small cell lung cancer or oligometastatic lung tumors

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Technical Efficacy RateTime frame: 30 days (+/- 7 days) post-ablation

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Beijing Hospital

    Beijing, China

  • Pecking University Shenzhen Hospital

    Beijing, China

  • The First Affiliated Hospital of Fujian Medical University

    Fujian, China

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.